Lu C - Search Results

1

Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growth.

Liu Y, Ludes-Meyers J, Zhang Y, Munoz-Medellin D, Kim HT, Lu C, Ge G, Schiff R, Hilsenbeck SG, Osborne CK, Brown PH. Liu Y, et al. Among authors: lu c. Oncogene. 2002 Oct 31;21(50):7680-9. doi: 10.1038/sj.onc.1205883. Oncogene. 2002. PMID: 12400010

2

Effect of epidermal growth factor receptor inhibitor on development of estrogen receptor-negative mammary tumors.

Lu C, Speers C, Zhang Y, Xu X, Hill J, Steinbis E, Celestino J, Shen Q, Kim H, Hilsenbeck S, Mohsin SK, Wakeling A, Osborne CK, Brown PH. Lu C, et al. J Natl Cancer Inst. 2003 Dec 17;95(24):1825-33. doi: 10.1093/jnci/djg117. J Natl Cancer Inst. 2003. PMID: 14679152

3

AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity.

Liu Y, Lu C, Shen Q, Munoz-Medellin D, Kim H, Brown PH. Liu Y, et al. Among authors: lu c. Oncogene. 2004 Oct 28;23(50):8238-46. doi: 10.1038/sj.onc.1207889. Oncogene. 2004. PMID: 15378019

4

cFos is critical for MCF-7 breast cancer cell growth.

Lu C, Shen Q, DuPré E, Kim H, Hilsenbeck S, Brown PH. Lu C, et al. Oncogene. 2005 Sep 29;24(43):6516-24. doi: 10.1038/sj.onc.1208905. Oncogene. 2005. PMID: 16027729

5

The AP-1 transcription factor regulates postnatal mammary gland development.

Shen Q, Zhang Y, Uray IP, Hill JL, Kim HT, Lu C, Young MR, Gunther EJ, Hilsenbeck SG, Chodosh LA, Colburn NH, Brown PH. Shen Q, et al. Among authors: lu c. Dev Biol. 2006 Jul 15;295(2):589-603. doi: 10.1016/j.ydbio.2006.03.042. Epub 2006 Apr 4. Dev Biol. 2006. PMID: 16678816 Free article.

6

Specific blockade of VEGF and HER2 pathways results in greater growth inhibition of breast cancer xenografts that overexpress HER2.

Le XF, Mao W, Lu C, Thornton A, Heymach JV, Sood AK, Bast RC Jr. Le XF, et al. Among authors: lu c. Cell Cycle. 2008 Dec;7(23):3747-58. doi: 10.4161/cc.7.23.7212. Epub 2008 Dec 16. Cell Cycle. 2008. PMID: 19029832 Free PMC article.

7

Targeting aurora kinase with MK-0457 inhibits ovarian cancer growth.

Lin YG, Immaneni A, Merritt WM, Mangala LS, Kim SW, Shahzad MM, Tsang YT, Armaiz-Pena GN, Lu C, Kamat AA, Han LY, Spannuth WA, Nick AM, Landen CN Jr, Wong KK, Gray MJ, Coleman RL, Bodurka DC, Brinkley WR, Sood AK. Lin YG, et al. Among authors: lu c. Clin Cancer Res. 2008 Sep 1;14(17):5437-46. doi: 10.1158/1078-0432.CCR-07-4922. Clin Cancer Res. 2008. PMID: 18765535 Free PMC article.

8

Antitumor and antivascular effects of AVE8062 in ovarian carcinoma.

Kim TJ, Ravoori M, Landen CN, Kamat AA, Han LY, Lu C, Lin YG, Merritt WM, Jennings N, Spannuth WA, Langley R, Gershenson DM, Coleman RL, Kundra V, Sood AK. Kim TJ, et al. Among authors: lu c. Cancer Res. 2007 Oct 1;67(19):9337-45. doi: 10.1158/0008-5472.CAN-06-4018. Cancer Res. 2007. PMID: 17909042

9

Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian cancer.

Kamat AA, Kim TJ, Landen CN Jr, Lu C, Han LY, Lin YG, Merritt WM, Thaker PH, Gershenson DM, Bischoff FZ, Heymach JV, Jaffe RB, Coleman RL, Sood AK. Kamat AA, et al. Among authors: lu c. Cancer Res. 2007 Jan 1;67(1):281-8. doi: 10.1158/0008-5472.CAN-06-3282. Cancer Res. 2007. PMID: 17210709

10

Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma.

Lu C, Bonome T, Li Y, Kamat AA, Han LY, Schmandt R, Coleman RL, Gershenson DM, Jaffe RB, Birrer MJ, Sood AK. Lu C, et al. Cancer Res. 2007 Feb 15;67(4):1757-68. doi: 10.1158/0008-5472.CAN-06-3700. Cancer Res. 2007. PMID: 17308118

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20,750 results

Search Page

Filters